Boston Globe: 'Knock out the middlemen' is a campaign promise Donald Trump should keep
In 2021, the FDA approved a new insulin drug, Semglee, that was interchangeable with a brand-name insulin called Lantus.
Hosted on MSN11mon
What to Do If Your Insulin Is Being Discontinued
Zilbermint highlights Lantus (insulin glargine ... U.S. sales of the FlexPen version of Levemir in April 2024 and Levemir vials by the end of December. While other insulins are available, you ...
pharmaphorum2d
Civica plans shake-up of insulin sector with low-cost biosimilars
The biosimilars – which will be interchangeable with Sanofi's Lantus (insulin glargine ... prices of the originator insulin are around $329 per vial and $510 for five pens, according to ...
Medscape2d
Room-temperature Storage of Medications Labeled for Refrigeration
28 days Prescribing information Insulin glargine (rDNA origin) vial or cartridge Lantus vial or cartridge (Sanofi-Aventis) 28 days Prescribing information 70% insulin aspart protamine suspension ...
pharmaphorum5d
California sues insulin producers and PBMs over pricing
According to research, one vial of Lilly's Humalog (insulin ... to launch biosimilars of three big-selling insulin products in the US – Sanofi's Lantus, Novo Nordisk's Novolog, and Lilly's ...
West Virginia MetroNews12d
Cochran trial: Vial tested for insulin submitted as evidence in murder trial
BECKLEY, W.Va. — An FBI chemist who tested a vial found in accused murderer Natalie Cochran’s refrigerator after the death of her husband testified Friday what was in the vial was consistent ...
The Boston Globe5d
‘Knock out the middlemen’: A campaign promise Donald Trump should keep
that was interchangeable with a brand-name insulin called Lantus. Lantus cost $292 for a 30-day supply. Drugmaker Viatris launched two versions of its drug — Semglee cost $269 and a generic ...